Physicians’ perception of guideline recommendations for the treatment of resistant hypertension by renal denervation: Resistant Hypertension Working Group, Argentine Hypertension Society

IF 1.3 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Hipertension y Riesgo Vascular Pub Date : 2025-04-01 DOI:10.1016/j.hipert.2024.10.003

N.F. Renna , L. Brandani , R. Parodi , C. Kotliar , E. Ylarri , G. Lavenia , M. Marin , M. Ruise , R. Sanchez , D. Cianfagna , G. Botvinik , P. Rumi , V. Ferreti , P. Rodríguez

{"title":"Physicians’ perception of guideline recommendations for the treatment of resistant hypertension by renal denervation: Resistant Hypertension Working Group, Argentine Hypertension Society","authors":"N.F. Renna , L. Brandani , R. Parodi , C. Kotliar , E. Ylarri , G. Lavenia , M. Marin , M. Ruise , R. Sanchez , D. Cianfagna , G. Botvinik , P. Rumi , V. Ferreti , P. Rodríguez","doi":"10.1016/j.hipert.2024.10.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>This study investigates the perceptions and knowledge of specialized Argentine physicians regarding renal denervation (RDN) as a treatment for resistant hypertension (R-HT).</div></div><div><h3>Method</h3><div>A survey was conducted among 206 physicians, mainly cardiologists and internists, to assess their awareness and perceptions of RDN. Data were analyzed using descriptive statistics and Spearman's Rho correlation.</div></div><div><h3>Results</h3><div>The survey revealed that 83% of the responders are aware of RDN. Despite this high awareness, only 60% believe in its safety, while 33.2% are uncertain, and 6.8% consider it unsafe. Significant correlations were found between the awareness of RDN and perceptions of its efficacy and safety.</div></div><div><h3>Conclusions</h3><div>The study highlights a gap between knowledge and confidence in RDN among specialized Argentine physicians. Continuous education and shared decision-making are crucial to improve the adoption of RDN in clinical practice. Long-term safety and efficacy data support RDN as a valuable tool for managing R-HT. Addressing safety concerns through targeted educational initiatives is essential.</div></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"42 2","pages":"Pages 79-84"},"PeriodicalIF":1.3000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hipertension y Riesgo Vascular","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1889183724001119","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction

This study investigates the perceptions and knowledge of specialized Argentine physicians regarding renal denervation (RDN) as a treatment for resistant hypertension (R-HT).

Method

A survey was conducted among 206 physicians, mainly cardiologists and internists, to assess their awareness and perceptions of RDN. Data were analyzed using descriptive statistics and Spearman's Rho correlation.

Results

The survey revealed that 83% of the responders are aware of RDN. Despite this high awareness, only 60% believe in its safety, while 33.2% are uncertain, and 6.8% consider it unsafe. Significant correlations were found between the awareness of RDN and perceptions of its efficacy and safety.

Conclusions

The study highlights a gap between knowledge and confidence in RDN among specialized Argentine physicians. Continuous education and shared decision-making are crucial to improve the adoption of RDN in clinical practice. Long-term safety and efficacy data support RDN as a valuable tool for managing R-HT. Addressing safety concerns through targeted educational initiatives is essential.

查看原文本刊更多论文

医生对肾去神经支配治疗顽固性高血压的指南建议的看法：阿根廷高血压学会顽固性高血压工作组。

简介：本研究调查了阿根廷专业医生对肾去神经支配（RDN）作为顽固性高血压（R-HT）治疗的认知和知识。方法：对206名内科医生（主要是心脏科医生和内科医生）进行调查，了解他们对RDN的认识和看法。数据分析采用描述性统计和Spearman’s Rho相关。结果：调查显示83%的应答者知道RDN。尽管有很高的认知度，但只有60%的人相信它的安全性，33.2%的人不确定，6.8%的人认为它不安全。对RDN的认知与对其有效性和安全性的认知之间存在显著的相关性。结论：该研究突出了阿根廷专业医生对RDN的知识和信心之间的差距。持续教育和共同决策对于提高临床实践中RDN的采用至关重要。长期安全性和有效性数据支持RDN作为治疗R-HT的宝贵工具。通过有针对性的教育举措解决安全问题至关重要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Hipertension y Riesgo Vascular Medicine-Internal Medicine

CiteScore

1.70

自引率

16.70%

发文量

审稿时长

39 days

期刊介绍： La mejor publicación para mantenerse al día en los avances de la lucha contra esta patología. Incluye artículos de Investigación, Originales, Revisiones, Casos clínicos, Aplicación práctica y Resúmenes comentados a la bibliografía internacional. Además, es la Publicación Oficial de la Sociedad española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial.